Loading...
By Amy Orciari Herman
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
Roughly 39,000 human papillomavirus-associated cancers (those at anatomic sites associated with HPV) were diagnosed in the U.S. each year from 2008 through 2012, according to an analysis in MMWR. The rate — 11.7 per 100,000 people — represents an increase over the previous 5-year period, when the rate was 10.8 per 100,000.
CDC researchers analyzed 2008–2012 data from population-based cancer registries. The most common HPV-associated cancers were cervical and oropharyngeal. Cervical cancers were diagnosed more often among blacks and Hispanics than whites. Oropharyngeal cancers were more common among males than females, while anal and rectal cancers were more common among females.
Of the HPV-associated cancers diagnosed each year, roughly 80% were actually attributable to HPV; of these, nearly 93% were caused by HPV strains for which vaccines are available.
"Increasing vaccination coverage could decrease the cancer incidence ... in the United States," the authors urge.
Comment
LINK(S):
MMWR article (Free)
Background: NEJM Journal Watch Women's Health coverage of study showing benefits of HPV vaccine (Your NEJM Journal Watch subscription required)